Claire Rosean

Director, Translational Research

Ms. Rosean has over 18 years of experience in basic and translational immuno-oncology research. Her scientific career spans a broad range of immune‑based therapeutic development, and she has contributed to advancing both foundational immunology and applied translational programs. Her work reflects a strong commitment to understanding immune mechanisms and applying that knowledge to support innovative therapeutic strategies.

Prior to joining Immunomic Therapeutics, she completed postdoctoral research at the University of Virginia, where she focused on breast cancer immunotherapy and contributed to research aimed at improving immune‑mediated treatment approaches.

Ms. Rosean holds a Bachelor of Arts in Biology from Saint Olaf College and a PhD in Immunology from the University of Iowa.